Paolo G. Vigneri
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review.
Journal: Pharmaceutics
Published: June 29, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.
Journal: Nature communications
Published: April 15, 2026
Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.
Journal: Critical reviews in oncology/hematology
Published: April 10, 2026
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study.
Journal: Breast (Edinburgh, Scotland)
Published: February 22, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.
Journal: Current oncology (Toronto, Ont.)
Published: February 10, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs.
Journal: Frontiers in pharmacology
Published: January 03, 2026
Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 26, 2025
Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2025
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2025
Last Updated: 09/26/2026